Sinphar Pharmaceutical Co Ltd (1734) — Free Cash Flow Generation Index
Sinphar Pharmaceutical Co Ltd (1734) has a Free Cash Flow Generation Index of 0.13x as of March 2026. Free cash flow of NT$15.34 Million represents 0% of operating cash flow (NT$116.42 Million). Explore capital reinvestment ratio of Sinphar Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinphar Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Sinphar Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see 1734 cash flow conversion.
Annual Free Cash Flow Generation for Sinphar Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Sinphar Pharmaceutical Co Ltd. Check Sinphar Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.66x | NT$383.72 Million | NT$584.66 Million | NT$200.94 Million | ▲ +15.7% |
| 2024 | 0.57x | NT$336.80 Million | NT$593.51 Million | NT$256.71 Million | ▲ +3783.3% |
| 2023 | -0.02x | NT$-4.57 Million | NT$296.37 Million | NT$300.94 Million | ▼ -102.4% |
| 2022 | 0.64x | NT$271.85 Million | NT$425.30 Million | NT$153.44 Million | ▲ +434.5% |
| 2021 | -0.19x | NT$-25.90 Million | NT$135.54 Million | NT$161.44 Million | ▼ -145.9% |
| 2020 | -0.08x | NT$-11.38 Million | NT$146.39 Million | NT$157.77 Million | ▲ +96.5% |
| 2018 | -2.22x | NT$-176.19 Million | NT$79.50 Million | NT$255.69 Million | ▼ -1097.0% |
| 2017 | 0.22x | NT$48.87 Million | NT$219.87 Million | NT$171.00 Million | ▲ +114.1% |
| 2016 | -1.58x | NT$-137.66 Million | NT$87.18 Million | NT$224.85 Million | ▼ -236.8% |
| 2015 | -0.47x | NT$-131.51 Million | NT$280.53 Million | NT$412.04 Million | ▲ +52.2% |
| 2014 | -0.98x | NT$-145.71 Million | NT$148.58 Million | NT$294.29 Million | ▲ +3.2% |
| 2013 | -1.01x | NT$-301.07 Million | NT$297.09 Million | NT$598.16 Million | ▲ +20.9% |
| 2012 | -1.28x | NT$-210.75 Million | NT$164.45 Million | NT$375.19 Million | ▼ -112.4% |
| 2011 | -0.60x | NT$-136.11 Million | NT$225.58 Million | NT$361.69 Million | ▼ -404.8% |
| 2010 | -0.12x | NT$-31.26 Million | NT$261.49 Million | NT$292.75 Million | ▼ -141.1% |
| 2009 | 0.29x | NT$90.23 Million | NT$309.94 Million | NT$219.71 Million | ▲ +109.0% |
| 2008 | 0.14x | NT$37.75 Million | NT$271.01 Million | NT$233.25 Million | ▼ -95.9% |
| 2007 | 3.37x | NT$589.76 Million | NT$174.85 Million | NT$414.90 Million | ▲ +35.1% |
| 2006 | 2.50x | NT$416.01 Million | NT$166.57 Million | NT$249.44 Million | ▼ -1.9% |
| 2005 | 2.55x | NT$310.86 Million | NT$122.09 Million | NT$188.76 Million | ▲ +32.6% |
| 2004 | 1.92x | NT$335.60 Million | NT$174.81 Million | NT$160.79 Million | ▼ -39.2% |
| 2003 | 3.16x | NT$381.33 Million | NT$120.84 Million | NT$260.50 Million | — |